SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 92 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $374,357 | -41.2% | 96,733 | -9.4% | 0.00% | 0.0% |
Q2 2023 | $636,349 | +79.4% | 106,770 | -1.6% | 0.00% | 0.0% |
Q1 2023 | $354,769 | -18.3% | 108,492 | -1.3% | 0.00% | 0.0% |
Q4 2022 | $434,054 | -33.3% | 109,887 | +1.2% | 0.00% | 0.0% |
Q3 2022 | $651,000 | -8.1% | 108,575 | -1.4% | 0.00% | 0.0% |
Q2 2022 | $708,000 | +24.4% | 110,093 | +59.8% | 0.00% | 0.0% |
Q1 2022 | $569,000 | -53.1% | 68,899 | -12.1% | 0.00% | 0.0% |
Q4 2021 | $1,213,000 | +15.4% | 78,386 | +68.0% | 0.00% | 0.0% |
Q3 2021 | $1,051,000 | +44.4% | 46,652 | +26.0% | 0.00% | 0.0% |
Q2 2021 | $728,000 | -54.0% | 37,027 | -21.8% | 0.00% | -50.0% |
Q1 2021 | $1,584,000 | – | 47,340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $220,158,000 | 8.29% |
Crestline Management, LP | 3,365,624 | $21,641,000 | 2.82% |
Omega Fund Management, LLC | 843,750 | $5,425,000 | 1.73% |
Alphabet Inc. | 2,812,500 | $18,084,000 | 0.98% |
HARVARD MANAGEMENT CO INC | 468,749 | $3,014,000 | 0.35% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 6,400,000 | $41,152,000 | 0.35% |
PFM Health Sciences, LP | 952,733 | $6,126,000 | 0.23% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 156,254 | $1,005,000 | 0.20% |
Viewpoint Capital Management LLC | 23,545 | $151,000 | 0.14% |
Artal Group S.A. | 400,000 | $2,572,000 | 0.14% |